Send to

Choose Destination
Toxicol Lett. 2003 Jul 20;143(2):133-43.

Thymoquinone protects against experimental colitis in rats.

Author information

Branch of the Department of Pharmacology, College of Medicine, King Saud University, P.O. Box 22452, 11461, Riyadh, Saudi Arabia.


The present work was done to investigate the possible effects of thymoquinone on acetic acid-induced colitis in rats. Colitis was induced by intracolonic injection of 3% acetic acid. Several parameters including macroscopic score, histopathological and biochemical, were determined to assess the degree of protection. Biochemical parameters such as myeloperoxidase activity, reduced glutathione levels, platelet activating factor (PAF) and histamine were measured following standard assay procedures. The study showed that pretreatment of rats for 3 days with thymoquinone (10 mg/kg) was able to give complete protection against acetic acid-induced colitis an effect significantly higher than sulfasalazine (500 mg/kg) control group. The smaller dose of thymoquinone (5 mg/kg) produced partial protection. Moreover, the biochemical and histopathological changes were reversed and brought towards the control. These results suggest a beneficial effect of thymoquinone against experimentally-induced colitis and the possible mechanism of the protective effects may be partly due to an antioxidant action.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center